ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1301

Trabecular Bone Impairment Assessed By HR-pQCT in Juvenile-Onset Systemic Lupus Erythematous with Vertebral Fractures

Juliane Paupitz, Glauce Lima, Valéria Caparbo, Henrique Fuller, Eloisa Bonfa and Rosa M R Pereira, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Bone, Bone density, fractures and juvenile SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Lupus, Scleroderma and Myositis (ACR)

Session Type: Abstract Submissions (ACR)

Background/Purpose

The three-dimensional evaluation of bone by HR-pQCT has the advantage to provide assessment to not only bone density, but also to a noninvasive evaluation of bone structure and bone strength. Information about changes in bone microarchitecture in juvenile-onset SLE (JoSLE) with and without fractures is lacking and they may improve future strategies of therapy and prediction of fracture risk in these patients. The objective of this study was, therefore, to analyze bone microarchitecture in JoSLE with and without vertebral fractures(VF).  

Methods

Twelve consecutive JoSLE female patients with VF according to Vertebral fracture assessment (VFA) by dual-energy X-ray absorptiometry (DXA)  were selected and compared to 44 female JoSLE patients without VF. Demographic, anthropometric, clinical and laboratory data were recorded by interview and electronic chart review. Bone microarchitecture was evaluated by High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT) at the distal radius.

Results

Patients with and without VF had comparable age (18.0±2.73 vs. 18.5±3.35 years, p=0.0636), BMI (23.03±4.39 vs. 23.15±3.45 kg/m2, p=0.927), disease duration (58.25 ± 45.03 vs. 71.39 ± 48.57 months, p=0.403), SLEDAI (4.14±4.04 vs. 4.73±5.92, p=0.744), CG cumulative dose (8602.71±8484.15 vs. 6291.54±6737.18 mg, p=0.454), current GC dose (16.04±14.44 vs. 15.97±19.75 mg/day, p=0.990), maximum GC dose (34.17±26.53 vs. 29.20±31.35 mg/day, p=0.466) and 25-hydroxyvitamin D (22.25 ± 6.93 vs. 23.38 ± 6.90 ng/ml, p=0.610). In spite of these comparable parameters, Table 1 illustrates significant differences in HR-pQCT in distal radius findings in the two groups of patients analyzed. Patients with vertebral fractures had reduced density parameters, particularly related to D100 (p=0.011) and D trab (p=0.024), suggesting a predominant trabecular bone involvement. Structural evaluation in patients with VF revealed a significant reduction in BV/TV (p=0.023) and Tb.Th (p=0.033), both parameters  associated with trabecular organization. Finally, a significant decrease in apparent modulus was observed in patients with VF (p=0.018) indicating a bone strength impairment of VF group.

Table 1:Density and Structural parameters of distal radius assessed HR-pQCT in JoSLE patients with and without vertebral fractures

 

HR-pQCT

Vertebral Fractures

 

(n=12)

No Vertebral

Fractures

(n=44)

P

Density Parameters

 

 

 

D 100, mg HA/ccm

229.45 ± 42.09

275.93 ± 56.87

0.011*

D trab, mg HA/ccm

136.96 ± 30.84

163.17 ± 35.45

0.024*

D comp, mg HA/ccm

742.83 ± 87.41

787.67 ± 105.88

0.122

Structural Parameters

 

 

 

BV/TV

0.114 ± 0.03

0.136 ± 0.03

0.023*

Tb.N, 1/mm

1.986 ± 0.31

2.123 ± 0.28

0.165

Tb.Th, mm

0.057 ± 0.01

0.064 ± 0.01

0.033*

Th.Sp, mm

0.461 ± 0.11

0.416 ± 0.07

0.129

Ct.Th, mm

0.428 ± 0.17

0.520 ± 0.22

0.189

Biomechanical Properties

 

 

 

Stiffness, kN/mm

61599.99 ± 34636.81

61814.79 ± 13493.61

0.071

Estimated Failure Load, N

3196.70 ± 2345.13

3005.52 ± 619.73

0.059

Apparent Modulus, N/mm²

1236.36 ± 334.85

1523.70 ± 367.14

0.018*

D100=average bone density; Dtrab=trabecular bone density; Dcomp=compact bone density; HA=hydroxyapatite; BV/TV=trabecular bone volume to tissue volume; Tb.N=trabecular number; Tb.Th=trabecular thickness; Tb.Sp=trabecular separation; Ct.Th=cortical thickness

Conclusion

The novel identification by a non-invasive technique (HRpQCT) that JoSLE patients with vertebral fractures have trabecular bone alterations with a significant reduction in bone strength opens a new perspective to define in future prospective studies the utility of this method for fracture prediction in this disease.


Disclosure:

J. Paupitz,
None;

G. Lima,
None;

V. Caparbo,
None;

H. Fuller,
None;

E. Bonfa,
None;

R. M. R. Pereira,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trabecular-bone-impairment-assessed-by-hr-pqct-in-juvenile-onset-systemic-lupus-erythematous-with-vertebral-fractures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology